mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
QL-X-138 |
GDSC1000 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
CAY10576 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.7 |
mRNA |
BI-2536 |
FIMM |
pan-cancer |
AAC |
0.07 |
0.7 |
mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
0.021 |
0.7 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |